What is a GLP-1 Receptor Agonist
123 PEG-loxenatide is used for blood glucose control in adult patients with T2DM
Kumar says some people consider this strategy, resuming the medication only after their weight begins to creep back up
Code 64B15-14.004): BMI 30 or 25 + comorbidity Comprehensive exam (can be delegated to APRN/PA) Written informed consent + Weight-Loss Consumer Bill of Rights Follow-ups every 3 months minimum PDMP (E-FORCSE) check before each controlled substance Rx Telehealth: Controlled substances CANNOT be prescribed via telehealth (except psychiatric disorders, inpatient, addiction treatment) Weight loss not on exception list phentermine via telehealth is illegal in FL GLP-1s (non-controlled) CAN be prescribed via telehealth with proper exam Out-of-state providers must register with FL Dept of Health Bottom line: Florida is the most restrictive state
61 ECC5004 The preliminary results of the investigational agent ECC5004 phase 1 trial in non-human primates revealed a reduction in HbA1c levels, accompanied by weight loss and a decreased risk of adverse cardiovascular events, achieved through the mimicry of the hormone GLP-1
Now, a new study presented at the American Diabetes Associations Scientific Session 2026 and published in the journal This study presented findings from a phase 2b randomized clinical trial called SOLSTICE to test the new oral GLP-1 medication elecoglipron